Papers

6

Total Citations

47

H-Index

4

About

Davide Maffei is a urological surgeon and researcher whose work is reshaping the management of prostate cancer through precision diagnostics and surgical innovation. His primary research focuses on improving the accuracy of preoperative staging—particularly in predicting extraprostatic extension (EPE) and lymph node invasion (LNI)—and on optimizing functional outcomes after robot-assisted radical prostatectomy (RARP). Maffei’s landmark 2022 study on high-resolution micro-ultrasound demonstrated its utility in predicting EPE prior to surgery, earning 26 citations and establishing a non-invasive alternative to multiparametric MRI. He has also advanced biochemical recurrence detection, showing in a prospective cohort that p2PSA can identify relapse earlier than total PSA. His external validation of the Briganti nomograms in the MRI era (5 citations) provides critical guidance for lymph node dissection decisions. Beyond diagnostics, Maffei has pioneered surgical techniques such as the retrotrigonal muscular layer sling for early continence recovery and developed structured rehabilitation programs for high-risk patients. With a growing portfolio of validated nomograms and translational studies, Maffei is driving the shift toward personalized, outcomes-driven prostate cancer care.

Research Focus

Key Achievements

4
H-Index
6
Papers
47
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study
26 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 39
🏛 Institutions: IRCCS Humanitas Research Hospital, Humanitas University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago